These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26273637)

  • 41. Determinants of incident prediabetes and type 2 diabetes in a 7-year cohort in a developing country: The Isfahan Cohort Study.
    Sadeghi M; Talaei M; Parvaresh Rizi E; Dianatkhah M; Oveisgharan S; Sarrafzadegan N
    J Diabetes; 2015 Sep; 7(5):633-41. PubMed ID: 25350916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabesity and brain disturbances: A metabolic perspective.
    Cardoso S; Moreira PI
    Mol Aspects Med; 2019 Apr; 66():71-79. PubMed ID: 30321556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mitochondrial dysfunction in type 2 diabetes and obesity.
    Højlund K; Mogensen M; Sahlin K; Beck-Nielsen H
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):713-31, x. PubMed ID: 18775360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A molecular bridge: connecting type 2 diabetes and Alzheimer's disease.
    Ahmed F; Ansari JA; Ansari ZE; Alam Q; Gan SH; Kamal MA; Ahmad E
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):312-21. PubMed ID: 24059325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive transcriptomic analysis indicates brain regional specific alterations in type 2 diabetes.
    Zhou Z; Zhu Y; Liu Y; Yin Y
    Aging (Albany NY); 2019 Aug; 11(16):6398-6421. PubMed ID: 31449493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A transcriptomic and proteomic atlas of obesity and type 2 diabetes in cynomolgus monkeys.
    Zhang X; Hu LG; Lei Y; Stolina M; Homann O; Wang S; Véniant MM; Hsu YH
    Cell Rep; 2023 Aug; 42(8):112952. PubMed ID: 37556324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SAGE application in the study of diabetes.
    Takamura T; Misu H; Yamashita T; Kaneko S
    Curr Pharm Biotechnol; 2008 Oct; 9(5):392-9. PubMed ID: 18855692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes.
    Jung S
    Exp Mol Med; 2018 Apr; 50(4):1-13. PubMed ID: 29674722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Network Based Approach in the Establishment of the Relationship between Type 2 Diabetes Mellitus and Its Complications at the Molecular Level Coupled with Molecular Docking Mechanism.
    Rampogu S; Rampogu Lemuel M
    Biomed Res Int; 2016; 2016():6068437. PubMed ID: 27699170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic Risk.
    Terenzi DC; Trac JZ; Teoh H; Gerstein HC; Bhatt DL; Al-Omran M; Verma S; Hess DA
    Trends Mol Med; 2019 Jul; 25(7):640-655. PubMed ID: 31053416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The double trouble of metabolic diseases: the diabetes-cancer link.
    Tudzarova S; Osman MA
    Mol Biol Cell; 2015 Sep; 26(18):3129-39. PubMed ID: 26371080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Bidirectional Relationship between Metabolism and Immune Responses.
    Raval FM; Nikolajczyk BS
    Discoveries (Craiova); 2013; 1(1):e6. PubMed ID: 26366435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Contributions of proteomics in the study of diabetes].
    Jiménez-Flores LM; Flores-Pérez EC; Mares-Álvarez DP; Macías-Cervantes MH; Ramírez-Emiliano J; Pérez-Vázquez V
    Gac Med Mex; 2014 Dec; 150 Suppl 1():88-94. PubMed ID: 25643683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Dysregulated Complement Activation Pathways Driven by N-Glycosylation Alterations in T2D Patients.
    Zhao Y; Wang M; Meng B; Gao Y; Xue Z; He M; Jiang Y; Dai X; Yan D; Fang X
    Front Chem; 2021; 9():677621. PubMed ID: 34178943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular aspects of signalling in diabesity.
    Sobrevia L; Desoye G
    Mol Aspects Med; 2019 Apr; 66():1-2. PubMed ID: 31018116
    [No Abstract]   [Full Text] [Related]  

  • 56. How exposure to chronic stress contributes to the development of type 2 diabetes: A complexity science approach.
    Merabet N; Lucassen PJ; Crielaard L; Stronks K; Quax R; Sloot PMA; la Fleur SE; Nicolaou M
    Front Neuroendocrinol; 2022 Apr; 65():100972. PubMed ID: 34929260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Type 2 Diabetes, Obesity, and Cancer Share Some Common and Critical Pathways.
    Rahman I; Athar MT; Islam M
    Front Oncol; 2020; 10():600824. PubMed ID: 33552973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrative network-based analysis of mRNA and microRNA expression in 1,25-dihydroxyvitamin D3-treated cancer cells.
    Kutmon M; Coort SL; de Nooijer K; Lemmens C; Evelo CT
    Genes Nutr; 2015 Sep; 10(5):35. PubMed ID: 26276506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of Comorbidities, Genomic Associations, and Molecular Mechanisms for COVID-19 Using Bioinformatics Approaches.
    Omit SBS; Akhter S; Rana HK; Rana ARMMH; Podder NK; Rakib MI; Nobi A
    Biomed Res Int; 2023; 2023():6996307. PubMed ID: 36685671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of inflammatory gene expression pathways in depressed patients with hyperphagia.
    de Kluiver H; Jansen R; Milaneschi Y; Penninx BWJH
    Transl Psychiatry; 2019 Aug; 9(1):193. PubMed ID: 31431611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.